EUCTR2014-003707-30-FR进行中（未招募）不适用
/A - INAUGURA
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
/AMedDRA version: 14.1Level: PTClassification code 10018209Term: Gestational diabetesSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2011-004221-28-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
进行中（未招募）
1 期
A Phase 1/2, First-in-Human, Open-Label, Dose Escalation and Expansion Study of STAR0602, a Selective T Cell Receptor (TCR) - targeting, Bifunctional Antibody-fusion molecule, in Subjects with Unresectable, Locally Advanced, or Metastatic Solid Tumors that are Antigen-Rich (START-001)nresectable, Locally Advanced, or Metastatic Solid TumorsCTIS2023-505334-10-00Marengo Therapeutics Inc.271
进行中（未招募）
1 期
Phase 1/2 study testing for the first time in humans a novel drug, STAR0602, to selectively stimulate T cells for the treatment of subjects with advanced solid tumors that cannot be removed with surgery or has spread locally or to other parts of the body.CTIS2023-505334-10-01Marengo Therapeutics Inc.271
进行中（未招募）
不适用
/AMild to moderate psoriasisEUCTR2007-003951-35-IEAlimentary Health Ltd60
进行中（未招募）
1 期
/AEUCTR2014-003436-39-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)14